Agios Pharma (8AP) Ownership - Who Owns Agios Pharma?
Agios Pharma (8AP) Ownership Overview
- 1.11% Insiders
- 25.31% Mutual Funds
- 3.50% Other Institutional Investors
- 21.37% ETFs
- 48.70% Public Companies and Individual Investors
The ownership structure of Agios Pharma (DE:8AP) stock is a mix of institutional, retail, and individual investors. Approximately 50.19% of the company’s stock is owned by Institutional Investors, 1.11% is owned by Insiders, and 48.70% is owned by Public Companies and Individual Investors.
The ownership structure of Agios Pharma (DE:8AP) stock is a mix of institutional, retail, and individual investors. Approximately 50.19% of the company’s stock is owned by Institutional Investors, 1.11% is owned by Insiders, and 48.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 04, 2026 | Theodore James Jr. Washburn | $152,255 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Woodline Partners Lp | €2,025,794 | |
| Dec 31, 2025 | Moore Capital Management Lp | €4,083,000 | |
| Dec 31, 2025 | Farallon Capital Management, L.l.c. | €140,441,726 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Andrew J.M. Spokes | 5,917,400 | Institution | 9.91% | 217,488,120 |
| Vanguard | 5,312,873 | Institution | 8.90% | 195,269,334 |
| Vanguard Index Funds | 4,724,824 | Institution | 7.91% | 173,656,181 |
| Delaware Group Equity Funds V | 4,489,301 | Institution | 7.52% | 164,999,769 |
| Ishares | 2,887,507 | Institution | 4.84% | 106,127,432 |
| Spdr | 2,030,388 | Institution | 3.40% | 74,624,881 |
| Dfa | 786,176 | Institution | 1.32% | 28,895,113 |
| Fidelity Salem Street Trust | 736,294 | Institution | 1.23% | 27,061,750 |
| Dfa Investment Dimensions Group Inc | 665,352 | Institution | 1.11% | 24,454,347 |
| Tiaa-cref Funds | 656,946 | Institution | 1.10% | 24,145,393 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,724,824 | Institution | 7.91% | 173,656,181 |
| Delaware Group Equity Funds V | 4,489,301 | Institution | 7.52% | 164,999,769 |
| Fidelity Salem Street Trust | 736,294 | Institution | 1.23% | 27,061,750 |
| Dfa Investment Dimensions Group Inc | 665,352 | Institution | 1.11% | 24,454,347 |
| Tiaa-cref Funds | 656,946 | Institution | 1.10% | 24,145,393 |
| Fidelity Concord Street Trust | 575,526 | Institution | 0.96% | 21,152,883 |
| Vanguard Scottsdale Funds | 399,757 | Institution | 0.67% | 14,692,669 |
| Fidelity Rutland Square Trust Ii | 373,695 | Institution | 0.63% | 13,734,786 |
| T. Rowe Price Quantitative Management Funds, Inc. | 290,281 | Institution | 0.49% | 10,668,988 |
| Blackrock Funds | 269,182 | Institution | 0.45% | 9,893,515 |
FAQ
Who Owns Agios Pharma (DE:8AP)?
According to the latest TipRanks data, approximately 50.19% of the company's stock is held by institutional investors, 1.11% is held by insiders, and 48.70% is held by public companies and individual investors.
What percentage of Agios Pharma (DE:8AP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.19% of Agios Pharma (DE:8AP) stock is held by institutional investors: 25.31% by mutual funds, 21.37% by ETFs and 3.50% by other institutional investors.
What percentage of Agios Pharma (DE:8AP) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.70% of Agios Pharma (DE:8AP) stock is held by public companies and individual investors.
Who owns the most shares of Agios Pharma (DE:8AP)?
Andrew J.M. Spokes owns the most shares of Agios Pharma (DE:8AP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.